Search research articles
Contact Us
Filters
Showing results (401-410 of 616) with videos related to
Page
of 62
Sort By:
American Journal of Physiology. Heart and Circulatory Physiology
|
December 22, 2023
Aldosterone and aldosterone synthase inhibitors in cardiorenal disease
Subodh Verma, Avinash Pandey, Arjun K Pandey, et al.
BMC Cardiovascular Disorders
|
November 14, 2023
Effect of empagliflozin on cardiac remodelling in South Asian and non-South Asian individuals: insights from the EMPA-HEART CardioLink-6 randomised clinical trial
William Barbour, Erika Wolff, Pankaj Puar, et al.
The Annals of Thoracic Surgery
|
July 17, 2023
Wearable Cardiac Rhythm Monitoring Device for Detection of Postoperative Atrial Fibrillation
Makoto Hibino, Arjun K Pandey, Subodh Verma, et al.
European Heart Journal
|
July 23, 2019
Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis
George C M Siontis, Pavel Overtchouk, Thomas J Cahill, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
May 1, 2020
Empagliflozin improves left ventricular diastolic function of db/db mice
Julia Moellmann, Barbara M Klinkhammer, Patrick Droste, et al.
The Canadian Journal of Cardiology
|
August 28, 2013
Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapy
Jean-François Tanguay, Alan D Bell, Margaret L Ackman, et al.
Journal of Cardiac Surgery
|
August 14, 2020
Learning curve predictors for minimally invasive mitral valve surgery; how far should the rabbit hole go?
Aleksander Dokollari, Matteo Cameli, Didar-Karan S Kalra, et al.
JACC. Basic to Translational Science
|
November 21, 2018
Empagliflozin Increases Cardiac Energy Production in Diabetes: Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors
Subodh Verma, Sonia Rawat, Kim L Ho, et al.
Journal of the American College of Cardiology
|
September 24, 2021
Prognostic Importance of NT-proBNP and Effect of Empagliflozin in the EMPEROR-Reduced Trial
James L Januzzi, Faiez Zannad, Stefan D Anker, et al.
Diabetes, Obesity & Metabolism
|
August 4, 2020
Effects of glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: Results of the LEADER and SUSTAIN 6 trials
Subodh Verma, Darren K McGuire, Stephen C Bain, et al.
Page
of 62
Search research articles
Search
Showing results (401-410 of 616) with videos related to
Sort By:
Page
of 62
American Journal of Physiology. Heart and Circulatory Physiology
|
December 22, 2023
Aldosterone and aldosterone synthase inhibitors in cardiorenal disease
Subodh Verma, Avinash Pandey, Arjun K Pandey, et al.
BMC Cardiovascular Disorders
|
November 14, 2023
Effect of empagliflozin on cardiac remodelling in South Asian and non-South Asian individuals: insights from the EMPA-HEART CardioLink-6 randomised clinical trial
William Barbour, Erika Wolff, Pankaj Puar, et al.
The Annals of Thoracic Surgery
|
July 17, 2023
Wearable Cardiac Rhythm Monitoring Device for Detection of Postoperative Atrial Fibrillation
Makoto Hibino, Arjun K Pandey, Subodh Verma, et al.
European Heart Journal
|
July 23, 2019
Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis
George C M Siontis, Pavel Overtchouk, Thomas J Cahill, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
May 1, 2020
Empagliflozin improves left ventricular diastolic function of db/db mice
Julia Moellmann, Barbara M Klinkhammer, Patrick Droste, et al.
The Canadian Journal of Cardiology
|
August 28, 2013
Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapy
Jean-François Tanguay, Alan D Bell, Margaret L Ackman, et al.
Journal of Cardiac Surgery
|
August 14, 2020
Learning curve predictors for minimally invasive mitral valve surgery; how far should the rabbit hole go?
Aleksander Dokollari, Matteo Cameli, Didar-Karan S Kalra, et al.
JACC. Basic to Translational Science
|
November 21, 2018
Empagliflozin Increases Cardiac Energy Production in Diabetes: Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors
Subodh Verma, Sonia Rawat, Kim L Ho, et al.
Journal of the American College of Cardiology
|
September 24, 2021
Prognostic Importance of NT-proBNP and Effect of Empagliflozin in the EMPEROR-Reduced Trial
James L Januzzi, Faiez Zannad, Stefan D Anker, et al.
Diabetes, Obesity & Metabolism
|
August 4, 2020
Effects of glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: Results of the LEADER and SUSTAIN 6 trials
Subodh Verma, Darren K McGuire, Stephen C Bain, et al.
Page
of 62